Parkman Healthcare Partners LLC
Q3 2026 13F filing
Updated 6 days ago91 disclosed positions worth $1.1B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P PTC THERAPEUTICS INC | $45.4M | 700.4K | 4.09% | — |
| 2 | L ELI LILLY & CO | $44.1M | 38.1K | 3.97% | — |
| 3 | M MBX BIOSCIENCES INC | $42M | 716.5K | 3.78% | — |
| 4 | I IQVIA HLDGS INC | $39M | 145.2K | 3.52% | — |
| 5 | D DEXCOM INC | $37.7M | 437.0K | 3.40% | — |
| 6 | I INHIBRX BIOSCIENCES INC | $36.1M | 360.3K | 3.25% | — |
| 7 | V VIRIDIAN THERAPEUTICS INC | $34.5M | 1.67M | 3.11% | — |
| 8 | U UROGEN PHARMA LTD | $30.5M | 750.2K | 2.75% | — |
| 9 | S SCHOLAR ROCK HLDG CORP | $26.1M | 540.0K | 2.35% | — |
| 10 | C CVS HEALTH CORP | $24.5M | 286.3K | 2.21% | — |
| 11 | A ALTO NEUROSCIENCE INC | $24.2M | 948.9K | 2.18% | — |
| 12 | M AGIOS PHARMACEUTICALS INC | $21.1M | 633.3K | 1.90% | — |
| 13 | S SYNDAX PHARMACEUTICALS INC | $20.8M | 1.11M | 1.87% | — |
| 14 | U UNITEDHEALTH GROUP INC | $20.5M | 55.9K | 1.85% | — |
| 15 | A AMYLYX PHARMACEUTICALS INC | $19.6M | 675.1K | 1.77% | — |
| 16 | A ASSEMBLY BIOSCIENCES INC | $18.7M | 796.3K | 1.68% | — |
| 17 | I INDIVIOR PHARMACEUTICALS INC | $18.7M | 521.6K | 1.68% | — |
| 18 | C CHARLES RIV LABS INTL INC | $17.7M | 60.0K | 1.59% | — |
| 19 | K KODIAK SCIENCES INC | $17.6M | 186.0K | 1.59% | — |
| 20 | R ARCUS BIOSCIENCES INC | $17.4M | 675.5K | 1.57% | — |
| 21 | A ADAPTIVE BIOTECHNOLOGIES COR | $17.3M | 600.1K | 1.56% | — |
| 22 | T TARSUS PHARMACEUTICALS INC | $16.8M | 213.4K | 1.51% | — |
| 23 | A ABBOTT LABORATORIES | $16.3M | 165.2K | 1.47% | — |
| 24 | T TENET HEALTHCARE CORP | $16.3M | 63.9K | 1.47% | — |
| 25 | X XERIS BIOPHARMA HOLDINGS INC | $15.7M | 1.64M | 1.41% | — |
| 26 | L LIVANOVA PLC | $15M | 195.6K | 1.35% | — |
| 27 | W WEST PHARMACEUTICAL SVSC INC | $14.8M | 40.0K | 1.34% | — |
| 28 | A AVALO THERAPEUTICS INC | $14.2M | 929.4K | 1.28% | — |
| 29 | A AVEANNA HEALTHCARE HLDGS INC | $14M | 1.13M | 1.26% | — |
| 30 | ? N/A SHOULDER INNOVATIONS INC | $13.7M | 726.9K | 1.24% | — |
| 31 | A ANI PHARMACEUTICALS INC | $13.5M | 185.9K | 1.22% | — |
| 32 | E EDGEWISE THERAPEUTICS INC | $13.3M | 328.0K | 1.20% | — |
| 33 | C CASTLE BIOSCIENCES INC | $13.1M | 367.9K | 1.18% | — |
| 34 | C CAREDX INC | $13M | 200.4K | 1.17% | — |
| 35 | A ATRICURE INC | $12.7M | 225.2K | 1.14% | — |
| 36 | W WATERS CORP | $12.2M | 27.9K | 1.10% | — |
| 37 | I INSMED INC | $12M | 105.1K | 1.08% | — |
| 38 | C CRYOPORT INC | $11.8M | 678.6K | 1.06% | — |
| 39 | S SCHRODINGER INC | $11.6M | 375.0K | 1.05% | — |
| 40 | J JAZZ PHARMACEUTICALS PLC | $11.6M | 50.1K | 1.04% | — |
| 41 | F 4D MOLECULAR THERAPEUTICS IN | $11M | 772.2K | 1.00% | — |
| 42 | C CARLSMED INC | $11M | 779.8K | 0.99% | — |
| 43 | C HEMAB THERAPEUTICS HLDGS INC | $10.2M | 329.3K | 0.91% | — |
| 44 | I IRHYTHM HOLDINGS INC | $9.7M | 85.7K | 0.88% | — |
| 45 | I INSPIRE MED SYS INC | $9M | 130.0K | 0.81% | — |
| 46 | T TEMPUS AI INC | $9M | 110.0K | 0.81% | — |
| 47 | N NUVECTIS PHARMA INC | $9M | 425.4K | 0.81% | — |
| 48 | G STRUCTURE THERAPEUTICS INC | $8.9M | 283.8K | 0.80% | — |
| 49 | C COGENT BIOSCIENCES INC | $8.8M | 275.8K | 0.80% | — |
| 50 | A ALNYLAM PHARMACEUTICALS INC | $8.7M | 35.2K | 0.78% | — |